Global Cysticercosis Treatment Market Size, Status and Forecast 2019-2025

Description

Cysticercosis or Taeniasis is an infection caused primarily due to tapeworms.
Globally, increasing government initiative to eradicate Cysticercosis, rise in the in incidences of Cysticercosis in developing regions, and increasing awareness among people for Cysticercosis are the prime growth drivers of global cysticercosis treatment market.
In 2018, the global Cysticercosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cysticercosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cysticercosis Treatment development in United States, Europe and China.

The key players covered in this study
GlaxoSmithKline
Amedra Pharmaceuticals
Bayer
Klarsehen India
Ranbaxy
Salius
Cipla
Pharmaco-Kinesis
Bonaide
Taj Pharmaceuticals

Market segment by Type, the product can be split into
Praziquantel
Albendazole

Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cysticercosis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Cysticercosis Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cysticercosis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cysticercosis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Praziquantel
1.4.3 Albendazole
1.5 Market by Application
1.5.1 Global Cysticercosis Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cysticercosis Treatment Market Size
2.2 Cysticercosis Treatment Growth Trends by Regions
2.2.1 Cysticercosis Treatment Market Size by Regions (2014-2025)
2.2.2 Cysticercosis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cysticercosis Treatment Market Size by Manufacturers
3.1.1 Global Cysticercosis Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Cysticercosis Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cysticercosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Cysticercosis Treatment Key Players Head office and Area Served
3.3 Key Players Cysticercosis Treatment Product/Solution/Service
3.4 Date of Enter into Cysticercosis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cysticercosis Treatment Market Size by Type (2014-2019)
4.2 Global Cysticercosis Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Cysticercosis Treatment Market Size (2014-2019)
5.2 Cysticercosis Treatment Key Players in United States
5.3 United States Cysticercosis Treatment Market Size by Type
5.4 United States Cysticercosis Treatment Market Size by Application

6 Europe
6.1 Europe Cysticercosis Treatment Market Size (2014-2019)
6.2 Cysticercosis Treatment Key Players in Europe
6.3 Europe Cysticercosis Treatment Market Size by Type
6.4 Europe Cysticercosis Treatment Market Size by Application

7 China
7.1 China Cysticercosis Treatment Market Size (2014-2019)
7.2 Cysticercosis Treatment Key Players in China
7.3 China Cysticercosis Treatment Market Size by Type
7.4 China Cysticercosis Treatment Market Size by Application

8 Japan
8.1 Japan Cysticercosis Treatment Market Size (2014-2019)
8.2 Cysticercosis Treatment Key Players in Japan
8.3 Japan Cysticercosis Treatment Market Size by Type
8.4 Japan Cysticercosis Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cysticercosis Treatment Market Size (2014-2019)
9.2 Cysticercosis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Cysticercosis Treatment Market Size by Type
9.4 Southeast Asia Cysticercosis Treatment Market Size by Application

10 India
10.1 India Cysticercosis Treatment Market Size (2014-2019)
10.2 Cysticercosis Treatment Key Players in India
10.3 India Cysticercosis Treatment Market Size by Type
10.4 India Cysticercosis Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Cysticercosis Treatment Market Size (2014-2019)
11.2 Cysticercosis Treatment Key Players in Central & South America
11.3 Central & South America Cysticercosis Treatment Market Size by Type
11.4 Central & South America Cysticercosis Treatment Market Size by Application

12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cysticercosis Treatment Introduction
12.1.4 GlaxoSmithKline Revenue in Cysticercosis Treatment Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 Amedra Pharmaceuticals
12.2.1 Amedra Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cysticercosis Treatment Introduction
12.2.4 Amedra Pharmaceuticals Revenue in Cysticercosis Treatment Business (2014-2019)
12.2.5 Amedra Pharmaceuticals Recent Development
12.3 Bayer
12.3.1 Bayer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cysticercosis Treatment Introduction
12.3.4 Bayer Revenue in Cysticercosis Treatment Business (2014-2019)
12.3.5 Bayer Recent Development
12.4 Klarsehen India
12.4.1 Klarsehen India Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cysticercosis Treatment Introduction
12.4.4 Klarsehen India Revenue in Cysticercosis Treatment Business (2014-2019)
12.4.5 Klarsehen India Recent Development
12.5 Ranbaxy
12.5.1 Ranbaxy Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cysticercosis Treatment Introduction
12.5.4 Ranbaxy Revenue in Cysticercosis Treatment Business (2014-2019)
12.5.5 Ranbaxy Recent Development
12.6 Salius
12.6.1 Salius Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cysticercosis Treatment Introduction
12.6.4 Salius Revenue in Cysticercosis Treatment Business (2014-2019)
12.6.5 Salius Recent Development
12.7 Cipla
12.7.1 Cipla Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cysticercosis Treatment Introduction
12.7.4 Cipla Revenue in Cysticercosis Treatment Business (2014-2019)
12.7.5 Cipla Recent Development
12.8 Pharmaco-Kinesis
12.8.1 Pharmaco-Kinesis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cysticercosis Treatment Introduction
12.8.4 Pharmaco-Kinesis Revenue in Cysticercosis Treatment Business (2014-2019)
12.8.5 Pharmaco-Kinesis Recent Development
12.9 Bonaide
12.9.1 Bonaide Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cysticercosis Treatment Introduction
12.9.4 Bonaide Revenue in Cysticercosis Treatment Business (2014-2019)
12.9.5 Bonaide Recent Development
12.10 Taj Pharmaceuticals
12.10.1 Taj Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cysticercosis Treatment Introduction
12.10.4 Taj Pharmaceuticals Revenue in Cysticercosis Treatment Business (2014-2019)
12.10.5 Taj Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Choose License Type

Checkout Inquiry Sample